Abstract
The aim of this study was to determine the inhibitory effect of clinically usable proteinase inhibitorsp-aminomethylbenzoic acid (PAMBA), and aprotinin on acantholysis in skin organ culture and in clinical trials with pemphigus patients. PAMBA added to the culture medium at a concentration of 1 mg/ml fully prevented the acantholysis, while Contrykal at 10 ATrE/ml reduced acantholysis. Subsequently, we treated 12 patients (group 1) with PAMBA 100–200 mg daily for 7 to 26 days in combination with a moderate dose of corticosteroid (mean dose 36.1 mg prednisolone equivalent) or immunosuppressive drugs. A second group of 12 patients (group 2) were treated with a high dose of corticosteroid (mean 94.2 mg prednisolone equivalent) and immunosuppressive drugs. Evaluation was performed before treatment, after 3 weeks and on discharge using a clinical scoring system. The inclusion of PAMBA in the treatment protocol of group 1 resulted in active disease being brought under control with lower corticosteroid doses. As a result, fewer side effects were observed in group 1 than in group 2. In our opinion, protease inhibitors may be useful as adjuvant drugs in the combination therapy of pemphigus.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Binder WL, Beutner EH, Chorzelski TP (1978) In vitro effects of pemphigus antibodies on skin. Br J Dermatol 99:39–42
Chorzelski TP, Rogozinski T, Sulej J (1979) Immunopathologic and histologic studies on skin from pemphigus patients in tissue culture. J Cutan Pathol 6:130–133
Farb RM, Dykes R, Lazarus CS (1978) Antiepithelial cell surface pemphigus antibodies detach viable epidermal cells from culture plates by activation of proteinase. Proc Natl Acad Sci USA 75:459–463
Michel B, Ko CS (1974) Effect of pemphigus or bullous pemphigoid sera and leucocytes on normal human skin in organ culture: an in vitro model for the study of bullous diseases J Invest Dermatol 62:541–542
Michel B, Ko CS (1977) An organ culture model for the study of pemphigus acantholysis. Br J Dermatol 96:295–302
Schiltz JR, Michel B (1976) Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol 67:254–260
Morioka S, Naito K, Ogawa H (1981) The pathogenic role of pemphigus antibodies and proteinases in epidermal acantholysis. J Invest Dermatol 76:337–341
Schiltz JR, Michel B, Papay R (1978) Pemphigus antibody interaction with human epidermal cells in culture: a proposed mechanism for pemphigus acantholysis. J Clin Invest 62:775–778
Schiltz JR, Michel B, Papay R (1979) Appearance of “pemphigus acantholysis factor” in human skin cultured with pemphigus antibody. J Invest Dermatol 73:575–581
Singer KH, Sanica NJ, Samovitz HR (1980) Proteinase activation: a mechanism for cellular dyshesion in pemphigus. J Invest Dermatol 74:363s
Singer KH, Hashimoto K, Lazarus GS (1983) Antibody induced proteinase activation: a proposed mechanism for pemphigus. In: Cigli I (ed) Immunodermatology. Springer, Berlin, pp 19–34
Woo TY, Hogan VA, Patel H, Anhalt G, Labib R, Voorhees J, Diaz L (1983) Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. J Invest Dermatol 81 [Suppl 1]: 115–121
Fabri P, Lotti T, Panconesi E (1985) Pathogenesis of pemphigus. The role of epidermal plasminogen activators in acantholysis. Int J Dermatol 24:422–425
Hashimoto K, Shafran KM, Weber PS (1983) Anti-cell surface pemphigus antibody stimulates plasminogen activator activity of human epidermal cells A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med 157:259–272
Takamori K, Yoshiike T, Morioka S (1988) The role of proteases in the pathogenesis of bullous dermatoses. Int J Dermatol 27:533–539
Jordon RE, Kawana S, Fritz KA (1985) Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol 85:72–78
Kawana S, Jonson M, Jordon RE (1984) Complement fixation by pemphigus antibody. I. In vitro fixation to organ and tissue culture skin. J Invest Dermatol 82:506–510
Hashimoto K, Wun TC, Baird J (1989) Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor. J Invest Dermatol 42:310–315
Popova L, Dobrev H, Vlashev D (1995) Experimental model of pemphigus vulgaris in diffusion chambers. Folia Med (Plovdiv) 3 (in press)
Georgiev I (1973) Cultures organotypiques in vitro en chambre a diffusion. Folia Med (Plovdiv) 6:323–327
Grando S (1992) Decompensation in proteinase-inhibitor system and application of proteinase inhibitors in pemphigus and pemphigoid. J Dermatol Sci 4:95–97
Essex-Sorlie D (1995) Medical biostatistics and epidemiology. Prentice-Hall International, London
Hassard TH (1991) Understanding biostatistics. Mosby Year Book, St. Louis
Hunziker T, Vassali JD (1987) Plasmin induces acantholysis in skin organ cultures. Arch Dermatol Res 279:341–346
Grando S, Glukhenky B, Romanenko A (1987) Endogenous proteinases and their inhibitors in the pathogenesis of pemphigus vulgaris (in Russian), Vestn Derm Venerol 8:4–7
Grando S, Glukhenky B, Barabash T, Zaslavsky L, Chernyavsky A (1990) Pathophysiologic disorders and experimental therapy in pemphigus and pemphigoid (in Russian). Vestn Derm Venerol 11:4–9
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dobrev, H., Popova, L. & Vlashev, D. Proteinase inhibitors and pemphigus vulgaris. An in vitro and in vivo study. Arch Dermatol Res 288, 648–655 (1996). https://doi.org/10.1007/BF02505273
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02505273